Portfolio
Membio
“Circularis controls the path to make the desired amount of protein in locations of interests. In manufacturing the goal most often is to make the most protein possible, while in gene therapy it is to express a very specific amount in a very specific subset of cells, while providing a therapeutic benefit. Circularis uses circular RNA as a reporter assay to tell what is happening in millions of cells in one tube. We read out the data with next-generation sequencing and then de-convolute it to identify DNA elements that create the protein expression profiles customers need.”
Backed By: KdT Ventures, Cantos Ventures, amongst others
